{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:08:03Z","timestamp":1789834083955,"version":"4.0.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,10]],"date-time":"2005-12-10T00:00:00Z","timestamp":1134172800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00228-005-0061-3","type":"journal-article","created":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T17:26:07Z","timestamp":1134149167000},"page":"29-36","source":"Crossref","is-referenced-by-count":91,"title":["The extent of induction of CYP3A by St. John\u2019s wort varies among products and is linked to hyperforin dose"],"prefix":"10.1007","volume":"62","author":[{"given":"Silke C.","family":"Mueller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Majcher-Peszynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Uehleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Klammt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf G.","family":"Mundkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Miekisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartwig","family":"Sievers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenther","family":"Kundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Drewelow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,10]]},"reference":[{"key":"61_CR1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1177\/0091270003252519","volume":"43","author":"TD Bjornsson","year":"2003","unstructured":"Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach SR, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA (2003) The conduct of in vitro and in vivo drug drug interaction studies: a PhRMA perspective. J Clin Pharmacol 43:443\u2013469","journal-title":"J Clin Pharmacol"},{"key":"61_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00213-002-1073-7","volume":"162","author":"V Butterweck","year":"2002","unstructured":"Butterweck V, Nahrstedt A, Evans J, Hufeisen S, Rauser L, Savage J, Popadak B, Ernsberger P, Roth BL (2002) In vitro receptor screening of pure constituents of St. John\u2019s wort reveals novel interactions with a number of GPCRs. Psychopharmacology 162:193\u2013202","journal-title":"Psychopharmacology"},{"key":"61_CR3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/00023210-200317080-00001","volume":"17","author":"V Butterweck","year":"2003","unstructured":"Butterweck V (2003) Mechanism of action of St. John\u2019s wort in depression\u2014What is known? CNS Drugs 17:539\u2013562","journal-title":"CNS Drugs"},{"key":"61_CR4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/ajhp\/59.6.545","volume":"59","author":"GC Reyes De los","year":"2002","unstructured":"De los Reyes GC, Koda RT (2002) Determining hyperforin and hypericin content in eight brands of St. John\u2019s wort. Am J Health Syst Pharm 59:545\u2013547","journal-title":"Am J Health Syst Pharm"},{"key":"61_CR5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/bmc.1130040105","volume":"4","author":"JX Vries De","year":"1990","unstructured":"De Vries JX, Rudi J, Walter-Sack I, Conradi R (1990) The determination of total and unbound midazolam in human plasma. A comparison of high performance liquid chromatography, gas chromatography and gas chromatography\/mass spectrometry. Biomed Chromatogr. 4:28\u201333","journal-title":"Biomed Chromatogr"},{"key":"61_CR6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-2125.2002.01223.x","volume":"53","author":"SN Wildt De","year":"2002","unstructured":"De Wildt SN, Kearns GL, Hop WC, Murry DJ, Abdel-Rahman SM, van den Anker JN (2002) Pharmacokinetics and metabolism of oral midazolam in preterm infants. Br J Clin Pharmacol. 53:390\u2013392","journal-title":"Br J Clin Pharmacol"},{"key":"61_CR7","first-page":"114","volume":"10","author":"AH Draves","year":"2003","unstructured":"Draves AH, Walker SE (2003) Analysis of the hypericin and pseudohypericin content of commercially available St. John\u2019s wort preparations. Can J Clin Pharmacol 10:114\u2013118","journal-title":"Can J Clin Pharmacol"},{"key":"61_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mcp.2003.10","volume":"73","author":"GK Dresser","year":"2003","unstructured":"Dresser GK, Schwarz UI, Wilkinson GR, Kim RB (2003) Coordinate induction of both cytochrome P4503A and MDR1 by St. John\u2019s wort in healthy subjects. Clin Pharmacol Ther 73:41\u201350","journal-title":"Clin Pharmacol Ther"},{"key":"61_CR9","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1067\/mcp.2000.112240","volume":"68","author":"D D\u00fcrr","year":"2000","unstructured":"D\u00fcrr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K (2000) St. John\u2019s wort induces intestinal p-glycoprotein\/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68:598\u2013604","journal-title":"Clin Pharmacol Ther"},{"key":"61_CR10","first-page":"3753","volume":"137","author":"F Gaedcke","year":"1997","unstructured":"Gaedcke F (1997) Johanniskraut und dessen Zubereitungen. Dtsch Apoth Ztg 137:3753\u20133757","journal-title":"Dtsch Apoth Ztg"},{"key":"61_CR11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1046\/j.1365-2125.2002.01683.x","volume":"54","author":"L Henderson","year":"2002","unstructured":"Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002) St. John\u2019s wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54:349\u2013356","journal-title":"Br J Clin Pharmacol"},{"key":"61_CR12","first-page":"1227","volume":"127","author":"J H\u00f6lzl","year":"1987","unstructured":"H\u00f6lzl J, Ostrowski E (1987) Johanniskraut (Hypericum perforatum): HPLC-Analyse der wichtigen Inhaltsstoffe und deren Variabilit\u00e4t in einer Population. Dtsch Apoth Ztg 127:1227\u20131230","journal-title":"Dtsch Apoth Ztg"},{"key":"61_CR13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1124\/dmd.32.5.512","volume":"32","author":"BJ Komoroski","year":"2004","unstructured":"Komoroski BJ, Zhang S, Cai H, Hutzler JM, Frye R, Tracy TS, Strom SC, Lehmann T, Ang CYW, Cui YY, Venkataramanan R (2004) Induction and inhibition of cytochromes P450 by the St. John\u2019s wort constituent hyperforin in human hepatocyte cultures. Drug Metab Dis 32:512\u2013518","journal-title":"Drug Metab Dis"},{"key":"61_CR14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.clpt.2004.07.004","volume":"76","author":"I Mai","year":"2004","unstructured":"Mai I, Bauer S, Perloff ES, Johne A, Uehleke B, Frank B, Budde K, Roots I (2004) Hyperforin content determines the magnitude of the St. John\u2019s wort\u2013cyclosporine drug interaction. Clin Pharmacol Ther 76:330\u2013340","journal-title":"Clin Pharmacol Ther"},{"key":"61_CR15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/00002018-200427110-00003","volume":"27","author":"M Mannel","year":"2004","unstructured":"Mannel M (2004) Drug interactions with St. John\u2019s wort\u2014mechanisms and clinical implications. Drug Safety 27:773\u2013797","journal-title":"Drug Safety"},{"key":"61_CR16","first-page":"56","volume":"138","author":"M Melzer","year":"1998","unstructured":"Melzer M, Fuhrken D, Kolkmann R (1998) Hyperforin im Johanniskraut\u2014Hauptwirkstoff oder nur Leitsubstanz? Dtsch Apoth Ztg 138:56\u201362","journal-title":"Dtsch Apoth Ztg"},{"key":"61_CR17","first-page":"560","volume":"4","author":"W Miekisch","year":"2003","unstructured":"Miekisch W, Fuchs P, Berg A, N\u00f6ldge-Schomburg G, Drewelow B, Mundkowski R (2003) An improved GC\/MS method for the determination of midazolam in human plasma. [abstract] Int J Clin Pharmacol Ther 4:560","journal-title":"[abstract] Int J Clin Pharmacol Ther"},{"key":"61_CR18","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1073\/pnas.130155097","volume":"97","author":"LB Moore","year":"2000","unstructured":"Moore LB, Goodwin B, Jones SA, Wisely GB, Serabjit-Singh CJ, Willson TM, Collins JL, Kliewer SA (2000) St John\u2019s wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci USA 97:7500\u20137502","journal-title":"Proc Natl Acad Sci USA"},{"key":"61_CR19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.clpt.2004.01.014","volume":"75","author":"SC Mueller","year":"2004","unstructured":"Mueller SC, Uehleke B, Woehling H, Petzsch M, Majcher-Peszynska J, Hehl E-M, Sievers H, Frank B, Rithling A-K, Drewelow B (2004) Effect of St. John\u2019s wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther 75:546\u2013557","journal-title":"Clin Pharmacol Ther"},{"key":"61_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clpt.2004.09.006","volume":"77","author":"BJ Ring","year":"2005","unstructured":"Ring BJ, Patterson BE, Mitchell MI, Vandenbranden M, Gillespie J, Bedding AW, Jewell H, Payne CD, Forgue ST, Ecksetin J, Wrighton SA, Phillips DL (2005) Effect of tadalafil on cytochrome P450 3A4-mediated clearance:studies in vitro and in vivo. Clin Pharmacol Ther 77:63\u201375","journal-title":"Clin Pharmacol Ther"},{"key":"61_CR21","doi-asserted-by":"crossref","DOI":"10.1002\/0471722103","volume-title":"Randomization in clinical trials","author":"WF Rosenberger","year":"2002","unstructured":"Rosenberger WF, Lachin JM (2002) Randomization in clinical trials. Wiley, New York"},{"key":"61_CR22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00008571-200004000-00001","volume":"10","author":"DS Streetman","year":"2000","unstructured":"Streetman DS, Bertino Jr JS, Nafziger AN (2000) Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes. Pharmacogenetics 10:187\u2013216","journal-title":"Pharmacogenetics"},{"key":"61_CR23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0009-9236(01)00127-8","volume":"70","author":"Z Wang","year":"2001","unstructured":"Wang Z, Gorski C, Hamman MA, Huang S-M, Lesko LJ, Hall SD (2001) The effects of St. John\u2019s wort (Hypericum perforatum) on human cytochrome P450 activity. Clin Pharmacol Ther 70:317\u2013326","journal-title":"Clin Pharmacol Ther"},{"key":"61_CR24","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1677\/joe.0.166R011","volume":"166","author":"JM Wentworth","year":"2000","unstructured":"Wentworth JM, Agostini M, Love J, Schwabe JW, Chatterjee VKK (2000) St. John\u2019s wort, a herbal antidepressant, activates the steroid X receptor. J Endocrinol 166:R11\u2013R16","journal-title":"J Endocrinol"},{"key":"61_CR25","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S1086-5802(16)31280-3","volume":"41","author":"M Wurglics","year":"2001","unstructured":"Wurglics M, Westerhoff K, Kaunzinger A, Wilke A, Baumeister A, Dressman J, Schubert-Zsilavecz M (2001) Comparison of German St. John\u2019s wort products according to hyperforin and total hypericin content. J Am Pharm Assoc 41:560\u2013566","journal-title":"J Am Pharm Assoc"},{"key":"61_CR26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1527-3458.2004.tb00022.x","volume":"10","author":"P Zanoli","year":"2004","unstructured":"Zanoli P (2004) Role of hyperforin in the pharmacological activities of St. John\u2019s wort. CNS Drug Rev 10:203\u2013218","journal-title":"CNS Drug Rev"},{"key":"61_CR27","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/0269881104042632","volume":"18","author":"S Zhou","year":"2004","unstructured":"Zhou S, Chan E, Pan S-Q, Huang M, Lee EJD (2004) Pharmacokinetic interactions of drugs with St John\u2019s wort. J Psychopharmacol 18:262\u2013276","journal-title":"J Psychopharmacol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0061-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-005-0061-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0061-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:50:44Z","timestamp":1706806244000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-005-0061-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,10]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["61"],"URL":"https:\/\/doi.org\/10.1007\/s00228-005-0061-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,10]]}}}